Integrated BioPharma, Inc. (INBP)
OTCMKTS
· Delayed Price · Currency is USD
0.290
-0.030 (-9.38%)
Nov 7, 2024, 3:00 PM EST
Integrated BioPharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 1.68 | 1.68 | 1.32 | 0.33 | 0.21 | 0.4 | Upgrade
|
| Short-Term Investments | - | - | - | 0.01 | 0.07 | 0.13 | Upgrade
|
| Cash & Short-Term Investments | 1.68 | 1.68 | 1.32 | 0.34 | 0.28 | 0.54 | Upgrade
|
| Cash Growth | 27.43% | 27.43% | 283.67% | 23.83% | -48.32% | -4.11% | Upgrade
|
| Receivables | 4.67 | 4.67 | 4.51 | 4.89 | 5.78 | 5.51 | Upgrade
|
| Inventory | 11.24 | 11.24 | 10.26 | 11.06 | 11.7 | 10.1 | Upgrade
|
| Other Current Assets | 0.29 | 0.29 | 0.28 | 0.34 | 0.25 | 0.32 | Upgrade
|
| Total Current Assets | 17.88 | 17.88 | 16.37 | 16.63 | 18 | 16.46 | Upgrade
|
| Property, Plant & Equipment | 3.68 | 3.68 | 4.28 | 3.78 | 4.11 | 4.52 | Upgrade
|
| Long-Term Deferred Tax Assets | 4.6 | 4.6 | 4.73 | 4.8 | 3.27 | 1.88 | Upgrade
|
| Other Long-Term Assets | 0.06 | 0.06 | 0.06 | 0.05 | 0.07 | 0.08 | Upgrade
|
| Total Assets | 26.21 | 26.21 | 25.43 | 25.25 | 25.44 | 22.94 | Upgrade
|
| Accounts Payable | 2.51 | 2.51 | 2.27 | 3.21 | 3.5 | 4.36 | Upgrade
|
| Accrued Expenses | 2.66 | 2.66 | 1.63 | 1.41 | 1.61 | 1.38 | Upgrade
|
| Short-Term Debt | - | - | - | 0.1 | 2.17 | 4.05 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 0.03 | 1.46 | 2.75 | Upgrade
|
| Current Portion of Leases | 0.95 | 0.95 | 0.93 | 0.51 | 0.5 | 0.56 | Upgrade
|
| Total Current Liabilities | 6.12 | 6.12 | 4.83 | 5.26 | 9.24 | 13.1 | Upgrade
|
| Long-Term Debt | - | - | - | 0.05 | - | 1.44 | Upgrade
|
| Long-Term Leases | 0.85 | 0.85 | 1.74 | 1.36 | 1.87 | 2.34 | Upgrade
|
| Total Liabilities | 6.97 | 6.97 | 6.57 | 6.68 | 11.11 | 16.88 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 51.5 | 51.5 | 51.24 | 50.92 | 50.52 | 50.26 | Upgrade
|
| Retained Earnings | -32.23 | -32.23 | -32.34 | -32.31 | -36.14 | -44.16 | Upgrade
|
| Treasury Stock | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | Upgrade
|
| Shareholders' Equity | 19.24 | 19.24 | 18.86 | 18.58 | 14.33 | 6.07 | Upgrade
|
| Total Liabilities & Equity | 26.21 | 26.21 | 25.43 | 25.25 | 25.44 | 22.94 | Upgrade
|
| Total Debt | 1.8 | 1.8 | 2.67 | 2.06 | 6 | 11.14 | Upgrade
|
| Net Cash (Debt) | -0.12 | -0.12 | -1.36 | -1.71 | -5.72 | -10.6 | Upgrade
|
| Net Cash Per Share | -0.00 | -0.00 | -0.05 | -0.05 | -0.18 | -0.34 | Upgrade
|
| Filing Date Shares Outstanding | 30.1 | 30.1 | 29.95 | 29.95 | 29.82 | 29.65 | Upgrade
|
| Total Common Shares Outstanding | 30.1 | 30.1 | 29.95 | 29.95 | 29.8 | 29.65 | Upgrade
|
| Working Capital | 11.75 | 11.75 | 11.54 | 11.36 | 8.76 | 3.36 | Upgrade
|
| Book Value Per Share | 0.64 | 0.64 | 0.63 | 0.62 | 0.48 | 0.20 | Upgrade
|
| Tangible Book Value | 19.24 | 19.24 | 18.86 | 18.58 | 14.33 | 6.07 | Upgrade
|
| Tangible Book Value Per Share | 0.64 | 0.64 | 0.63 | 0.62 | 0.48 | 0.20 | Upgrade
|
| Land | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | Upgrade
|
| Machinery | 7.22 | 7.22 | 6.8 | 6.73 | 6.42 | 6.47 | Upgrade
|
| Leasehold Improvements | 1.34 | 1.34 | 1.37 | 1.37 | 1.36 | 1.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.